Private Equity Firms

OrbiMed

OrbiMed is a PE firm that backs tech ventures.

Venture Investor Overview

Venture Investor
OrbiMed
Status
Active
Investor Type
Private Equity
Activity Level
380 transactions
Funds Raised
At least $9.2 billion
Industry Focus
AdTech
Artificial Intelligence
Biopharmaceutical
Healthcare IT
Healthcare Services
Life Sciences
Medical Devices & Instruments

Contact Information

Contact
Carl Gordon
Title
General Partner
Mailing Address
601 Lexington Ave. 54th floor
New York, NY 10022
USA
Phone
(212) 739-6400
Website
www.orbimed.com
Email Address
Not Recorded

Background Information

Overview
We have been investors in private equity since 1993. Our venture capital strategy is focused on drug development, drug discovery and medical device companies. We are active at all stages of development, with a particular emphasis on mid- and later-stage private companies. As one of the largest asset management firms dedicated to the life sciences, OrbiMed is generally a lead investor and takes an active role in helping management to achieve strategic, financial and operational objectives via participation at the Board of Directors level.
Profile
OrbiMed LinkedIn Company Profile
Social Media
OrbiMed Company Twitter Account
Company News
OrbiMed News
Facebook
OrbiMed on Facebook
YouTube
OrbiMed on YouTube
Last Transaction
11/12/2024

Transaction History

Our records indicate that OrbiMed invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Alentis Therapeutics
11/12/2024
$181,400,000
Leal Therapeutics
10/30/2024
$45,000,000
Triveni Bio
10/2/2024
$115,000,000
Candid Therapeutics
9/9/2024
$370,000,000
Magenta Medical
7/23/2024
$105,000,000
Brenig Therapeutics
7/23/2024
$65,000,000
Scorpion Therapeutics
7/16/2024
$150,000,000
Asceneuron
7/16/2024
$100,000,000
Exsilio Therapeutics
6/25/2024
$82,000,000
Q32 Bio
3/25/2024
$42,000,000
Mirador Therapeutics
3/25/2024
$400,000,000
Capstan Therapeutics
3/21/2024
$175,000,000
Sionna Therapeutics
3/7/2024
$182,000,000
ProfoundBio
2/13/2024
$112,000,000
BioAge Labs
2/13/2024
$170,000,000
Tyra Biosciences
2/2/2024
$200,000,000
Nanotronics
1/8/2024
Unknown
Odyssey Therapeutics
12/5/2023
$101,000,000
Koya Medical
11/15/2023
$30,000,000
Forward Therapeutics
11/8/2023
$50,000,000
Triveni Bio
10/26/2023
$92,000,000
Rampart Bioscience
10/24/2023
$85,000,000
MinervaX
10/11/2023
$56,768,000
Iambic Therapeutics
10/6/2023
$100,000,000
Adela
9/26/2023
$48,000,000
ReCode Therapeutics
9/19/2023
$50,000,000
Corteria Pharmaceuticals
9/7/2023
$69,640,000
Star Therapeutics
9/5/2023
$90,000,000
Epigenic Therapeutics
8/30/2023
$32,000,000
Fore Biotherapeutics
8/25/2023
$75,000,000
ADARx Pharmaceuticals
8/9/2023
$200,000,000
Upstream Bio
6/10/2023
$200,000,000
Convergent Therapeutics
5/3/2023
$90,000,000
Magenta Medical
5/3/2023
$55,000,000
Aer Therapeutics
4/14/2023
$36,000,000
ArriVent Biopharma
3/27/2023
$155,000,000
Congruence Therapeutics
3/6/2023
$65,000,000
TandemAI
3/1/2023
$35,000,000
Disc Medicine
2/14/2023
$62
Garuda Therapeutics
2/7/2023
$62,000,000
ADARx Pharmaceuticals
1/20/2023
$46,000,000
Caris Life Sciences
1/19/2023
$400,000,000
Pathalys Pharma
1/18/2023
$150,000,000
Amolyt Pharma
1/9/2023
$138,000,000
iECURE
11/30/2022
$65,000,000
MBX Biosciences
11/14/2022
$115,000,000
PIC Therapeutics
10/19/2022
$35,000,000
Treeline Biosciences
10/17/2022
$261,300,000
Odyssey Therapeutics
10/13/2022
$168,000,000
ACELYRIN
9/13/2022
$300,000,000
Frontera Therapeutics
7/20/2022
$160,000,000
Delfi Diagnostics
7/18/2022
$225,000,000
MiroBio
6/29/2022
$97,000,000
Charm Therapeutics
6/10/2022
$50,000,000
Upstream Bio
6/2/2022
$200,000,000
Terremoto Biosciences
5/25/2022
$75,000,000
Aspen Neuroscience
5/9/2022
$147,500,000
Sionna Therapeutics
4/21/2022
$111,000,000
MDClone
3/26/2022
$63,000,000
Electra Therapeutics
2/25/2022
$84,000,000
Third Harmonic Bio
2/25/2022
$105,000,000
ImmPACT Bio USA
1/28/2022
$111,000,000
TandemAI
12/29/2021
$25,000,000
ACELYRIN
11/17/2021
$250,000,000
PierianDx
11/3/2021
$47,500,000
ReCode Therapeutics
10/23/2021
$80,000,000
Garuda Therapeutics
9/24/2021
$72,000,000
Vanqua Bio
9/15/2021
$85,000,000
ADARx Pharmaceuticals
9/14/2021
$75,000,000
iECURE
9/10/2021
$50,000,000
Disc Medicine
9/2/2021
Unknown
Neurogastrx
8/27/2021
$60,000,000
Vigil Neuroscience
8/19/2021
$90,000,000
Carrot Fertility
8/19/2021
$75,000,000
Turnstone Biologics
7/22/2021
$80,000,000
Entos
7/15/2021
$53,000,000
Adela
6/24/2021
$60,000,000
RayzeBio
6/16/2021
$108,000,000
binx health
6/2/2021
$104,000,000
Sparrow Pharmaceuticals
5/19/2021
$50,000,000
Gennao Bio
5/11/2021
$40,000,000
Janux Therapeutics
4/21/2021
$125,000,000
Adagio Therapeutics
4/20/2021
$336,000,000
Theseus Pharmaceuticals
4/14/2021
$100,000,000
Crossover Health
3/30/2021
$168,000,000
Scribe Therapeutics
3/25/2021
$100,000,000
Graphite Bio
3/16/2021
$150,000,000
Ventyx Biosciences
3/10/2021
$114,000,000
BlossomHill Therapeutics
3/5/2021
$71,000,000
Century Therapeutics
3/4/2021
$160,000,000
Janux Therapeutics
3/4/2021
$56,000,000
Clover Biopharmaceuticals
2/25/2021
$230,000,000
Delfi Diagnostics
1/19/2021
$100,000,000
Delfi Diagnostics
1/18/2021
$100,000,000
Scorpion Therapeutics
1/8/2021
$162,000,000
Ikena Oncology
1/6/2021
$120,000,000
Terns Pharmaceuticals
1/6/2021
$87,000,000
Edgewise Therapeutics
12/10/2020
$95,000,000
RayzeBio
12/9/2020
$105,000,000
Adagio Therapeutics
11/11/2020
$80,000,000
Decibel Therapeutics
11/10/2020
$82,000,000
Cytek Biosciences
11/6/2020
$120,000,000
Q32 Bio
10/30/2020
$60,000,000
Caris Life Sciences
10/28/2020
$310,000,000
Olema Oncology
10/2/2020
$85,000,000
InventisBio
9/30/2020
$147,000,000
Galecto
9/28/2020
$64,000,000
Silverback Therapeutics
9/24/2020
$85,000,000
NeuroPace
9/2/2020
$67,000,000
Erasca
9/2/2020
$36,000,000
ReViral
8/26/2020
$44,000,000
Kinnate Biopharma
8/26/2020
$98,000,000
Prelude Therapeutics
8/25/2020
$50,000,000
ImmPACT Bio USA
8/21/2020
$18,000,000
Chinook Therapeutics
8/20/2020
$106,000,000
Aerin Medical
8/19/2020
$48,000,000
GentiBio
8/6/2020
$20,000,000
PMV Pharmaceuticals
8/4/2020
$70,000,000
MBX Biosciences
7/29/2020
$34,600,000
Adagio Therapeutics
7/17/2020
$50,000,000
Unum Therapeutics
7/10/2020
$104,400,000
Harbour BioMed
7/10/2020
$102,800,000
VelosBio
7/9/2020
$137,000,000
Q32 Bio
5/29/2020
$46,000,000
AbCellera
5/28/2020
$105,000,000
Aspen Neuroscience
4/2/2020
$70,000,000
Pandion Therapeutics
4/2/2020
$80,000,000
ReCode Therapeutics
3/27/2020
$80,000,000
Silverback Therapeutics
3/12/2020
$78,500,000
Sonendo
1/8/2020
$85,000,000
Kinnate Biopharma
12/20/2019
$74,500,000
Aspen Neuroscience
12/13/2019
$6,500,000
Adicet Bio
10/4/2019
$80,000,000
Edgewise Therapeutics
9/18/2019
$50,000,000
Repare Therapeutics
9/5/2019
$82,500,000
MDClone
8/26/2019
$26,000,000
GrayBug Vision
8/21/2019
$80,000,000
Cleave Therapeutics
8/8/2019
$12,000,000
Acutus Medical
6/21/2019
$170,000,000
Prelude Therapeutics
6/13/2019
$60,000,000
Fusion Pharmaceuticals
4/3/2019
$105,000,000
SpringWorks Therapeutics
4/2/2019
$125,000,000
Prevail Therapeutics
3/28/2019
$50,000,000
Imara Inc.
3/19/2019
$63,000,000
InventisBio
3/13/2019
$70,000,000
Peloton Therapeutics
2/21/2019
$150,000,000
Passage Bio
2/19/2019
$115,500,000
Health Catalyst
2/8/2019
$100,000,000
Apollomics
1/8/2019
$100,000,000
NextCure
11/14/2018
$93,000,000
Harpoon Therapeutics
11/13/2018
$70,000,000
Terns Pharmaceuticals
10/31/2018
$80,000,000
89Bio
10/26/2018
$60,000,000
TP Therapeutics
10/22/2018
$80,000,000
Modis Therapeutics
10/2/2018
$30,000,000
Silverback Therapeutics
9/20/2018
$47,500,000
Alector
7/26/2018
$133,000,000
Compass Therapeutics
7/13/2018
$49,000,000
Sublimity Therapeutics
5/23/2018
$64,000,000
Avedro
5/3/2018
$25,000,000
Attenua
5/1/2018
$35,000,000
Synthorx
5/1/2018
$63,000,000
Constellation Pharmaceuticals
4/10/2018
$100,000,000
Arvinas
4/5/2018
$55,000,000
Crinetics Pharmaceuticals
3/15/2018
$63,500,000
SmartZyme
3/15/2018
Unknown
Prevail Therapeutics
3/9/2018
$75,000,000
ORIC Pharmaceuticals
2/22/2018
$50,000,000
MDClone
2/6/2018
$15,000,000
Tyto Care
1/30/2018
$25,000,000
Neurogastrx
1/5/2018
$45,000,000
Kyn Therapeutics
12/15/2017
$49,000,000
Pionyr Immunotherapeutics
12/14/2017
$62,000,000
Atox Bio
12/5/2017
$30,000,000
resTORbio
12/1/2017
$40,000,000
RDD Pharma
11/17/2017
$9,500,000
Tricida
11/9/2017
$57,500,000
NeuroPace
10/25/2017
$74,000,000
Gemini Therapeutics
10/18/2017
$42,500,000
SpringWorks Therapeutics
9/26/2017
$103,000,000
Sonendo
9/19/2017
$50,000,000
Cyrus Biotechnology
7/28/2017
$8,000,000
E-Scape Bio
7/13/2017
$63,000,000
MobileODT
7/6/2017
$6,825,000
LogicBio Therapeutics
6/29/2017
$45,000,000
Avitide
6/22/2017
Unknown
Tisbury Pharmaceuticals
6/17/2017
$32,000,000
InventisBio
6/1/2017
$19,000,000
TP Therapeutics
5/24/2017
$45,000,000
Guardant Health
5/12/2017
$360,000,000
Avedro
4/27/2017
$42,000,000
Arsanis
4/27/2017
$45,500,000
Promentis Pharmaceuticals
3/31/2017
$26,000,000
PMV Pharmaceuticals
2/23/2017
$74,000,000
RHYTHM Health
2/18/2017
$41,000,000
TherAchon
1/11/2017
$5,000,000
scPharmaceuticals
1/5/2017
$45,600,000
Pionyr Immunotherapeutics
1/5/2017
$8,000,000
Augmedix
12/9/2016
$23,000,000
Turnstone Biologics
11/3/2016
$41,400,000
CBT Pharmaceuticals
8/31/2016
$9,750,000
Cleave Biosciences
8/9/2016
$37,000,000
Ornim
8/4/2016
$20,000,000
Tricida
7/26/2016
$55,000,000
Alpine Immune Sciences
6/14/2016
$48,000,000
Nucleix
5/25/2016
$3,000,000
GrayBug Vision
5/2/2016
$44,500,000
Kala Pharmaceuticals
4/14/2016
$68,000,000
Acutus Medical
3/22/2016
$75,000,000
Synlogic
2/17/2016
$40,000,000
Armo Bio Sciences
2/10/2016
$50,000,000
Adicet Bio
1/28/2016
$51,000,000
GENEWIZ
1/13/2016
Unknown
NextCure
1/7/2016
$67,000,000
Alector
1/7/2016
$29,500,000
Guardant Health
1/7/2016
$100,000,000
RHYTHM Health
12/31/2015
$15,000,000
True North Therapeutics
12/3/2015
$40,000,000
ORIC Pharmaceuticals
12/3/2015
$53,000,000
Avedro
11/16/2015
$32,000,000
TigerText
11/11/2015
$50,000,000
SmartZyme
10/28/2015
$4,000,000
Arvinas
10/21/2015
$41,600,000
Audentes Therapeutics
10/14/2015
$65,000,000
TherAchon
10/1/2015
$35,000,000
Corvus Pharmaceuticals
9/30/2015
$75,000,000
Alector
9/16/2015
$32,275,003
Selecta Biosciences
9/8/2015
$38,000,000
Intellia Therapeutics
9/1/2015
$70,000,000
Syndax Pharmaceuticals
8/24/2015
$80,000,000
Avitide
8/6/2015
Unknown
Corvus Pharmaceuticals
7/1/2015
$33,500,000
Clementia Pharmaceuticals
6/24/2015
$60,000,000
Sikka Software
6/18/2015
$10,500,000
Symbiomix Therapeutics
5/6/2015
$41,000,000
Dimension Therapeutics
4/21/2015
$65,000,000
Nabriva Therapeutics
4/13/2015
$120,000,000
True North Therapeutics
4/7/2015
Unknown
Natera
4/6/2015
$55,500,000
Tricida
3/5/2015
$30,000,000
Clementia Pharmaceuticals
1/5/2015
$10,000,000
Aduro BioTech
12/31/2014
$51,388,000
PMV Pharmaceuticals
12/3/2014
$30,000,000
Audentes Therapeutics
12/3/2014
$42,500,000
MID Labs
10/18/2014
$51,000,000
RPS Diagnostics
10/14/2014
$28,000,000
Invitae
10/13/2014
$120,000,000
Sonendo
9/5/2014
$35,000,007
Civitas Therapeutics
8/25/2014
$55,000,000
Dimension Therapeutics
6/23/2014
$30,000,000
Armo Bio Sciences
5/28/2014
$30,000,000
Inspire Medical Systems
5/15/2014
$40,000,000
Loxo Oncology
5/6/2014
$24,000,000
Otonomy
4/30/2014
$49,000,000
SI-BONE
4/28/2014
$33,000,000
Aerpio Pharmaceuticals
4/23/2014
$22,000,000
Principia Biopharma
4/22/2014
$50,000,000
ProNAi Therapeutics
4/22/2014
$59,500,000
Marina Biotech
3/13/2014
$38,000,000
Domain Surgical
3/5/2014
$35,000,000
Igenica
1/28/2014
$14,000,000
TigerText
1/27/2014
$21,000,000
Clementia Pharmaceuticals
1/10/2014
$22,500,000
Acerta Pharma
12/31/2013
$13,000,100
ViewRay
12/17/2013
$30,000,000
Armo Bio Sciences
11/26/2013
$20,000,000
Iroko Pharmaceuticals
11/21/2013
$75,000,000
Alector
11/1/2013
Unknown
Seragon Pharmaceuticals
10/18/2013
$30,000,000
Loxo Oncology
10/4/2013
$33,000,000
Arsanis
9/30/2013
$12,999,900
Practice Fusion
9/24/2013
$70,000,000
Otonomy
9/4/2013
Unknown
Arsanis
9/3/2013
$20,000,000
Audentes Therapeutics
7/19/2013
$30,000,000
Igenica
6/30/2013
$13,030,100
Acutus Medical
6/13/2013
$28,000,000
Singulex
6/7/2013
$15,000,000
Sonendo
6/5/2013
$18,000,000
Natera
5/1/2013
$54,600,000
Treato
4/30/2013
$14,500,000
Avitide
3/16/2013
$1,449,999
Glaukos
2/8/2013
$30,000,000
Igenica
12/31/2012
$10,250,000
ViewRay
12/31/2012
$5,872,000
CeraPedics
12/12/2012
$19,000,000
CardiAQ Valve Technologies
11/29/2012
$37,300,000
Cardioxyl Pharmaceuticals
11/7/2012
$28,050,000
Ambit Biosciences
11/6/2012
$50,000,000
Principia Biopharma
10/29/2012
$12,500,000
Aragon Pharmaceuticals
9/26/2012
$49,999,988
OmniGuide Surgical
8/28/2012
$35,000,000
Intercept Pharmaceuticals
8/13/2012
$30,000,000
Sonendo
6/29/2012
$20,000,000
Igenica
6/12/2012
$33,000,000
Good Start Genetics
4/2/2012
$14,000,000
Singulex
3/31/2012
$15,336,000
Kalidex Pharmaceuticals
3/31/2012
$6,499,900
Sientra
3/29/2012
$65,000,000
ViewRay
3/13/2012
$45,000,000
Aragon Pharmaceuticals
3/6/2012
$42,000,000
Roka Bioscience
1/9/2012
$47,500,000
Acceleron Pharma
12/23/2011
$30,000,000
Rempex Pharmaceuticals
11/9/2011
$67,500,000
DFINE
11/8/2011
$25,000,000
Arteaus Therapeutics
10/19/2011
$18,000,000
Cleave Biosciences
10/11/2011
$42,000,000
Puma Biotechnology
10/5/2011
$55,000,000
superDimension
9/30/2011
$11,000,000
Minnow Medical
8/3/2011
$23,000,000
Roka Bioscience
7/28/2011
$20,000,000
Ambit Biosciences
6/10/2011
$30,000,000
Crown Bioscience
5/3/2011
$28,800,000
Arsanis
2/8/2011
$10,000,000
Bonovo Orthopedics
12/23/2010
$10,000,000
Arsanis
9/30/2010
$400,000
Relypsa
9/13/2010
$70,000,000
Good Start Genetics
9/10/2010
$18,000,000
ViewRay
8/25/2010
$20,000,000
Complete Genomics
8/19/2010
$39,000,000
DFINE
7/7/2010
$36,200,000
superDimension
6/30/2010
$9,800,000
Igenica
6/11/2010
$24,000,000
Aragon Pharmaceuticals
4/23/2010
$22,000,000
Selecta Biosciences
4/5/2010
$15,000,000
Acceleron Pharma
12/31/2009
$10,951,000
Adimab
10/1/2009
Unknown
Amnis
9/30/2009
$830,000
Roka Bioscience
9/30/2009
$37,200,000
Complete Genomics
8/24/2009
$45,000,000
Enobia Pharma
8/10/2009
$50,000,000
Aragon Pharmaceuticals
5/21/2009
$8,000,000
CeraPedics
4/6/2009
$15,000,000
Singulex
1/14/2009
$19,000,000
Pacira Pharmaceuticals
12/31/2008
$55,000,000
Kreogene
12/31/2008
$350,000
Igenica
12/31/2008
$3,099,900
Adimab
11/20/2008
Unknown
Biolex
10/6/2008
$60,000,000
ChemoCentryx
10/2/2008
$50,000,000
MacroGenics
9/25/2008
$25,000,000
ForteBio
9/24/2008
$25,000,000
InteKrin Therapeutics
8/4/2008
$18,250,000
Apoptos
5/6/2008
$28,000,000
Pacira Pharmaceuticals
3/31/2008
$14,999,900
ViewRay
1/22/2008
$25,000,000
Gelesis
1/3/2008
$16,000,000
Ambit Biosciences
11/14/2007
$49,300,000
Acceleron Pharma
10/30/2007
$31,000,000
CeraPedics
10/8/2007
$14,450,000
NeurAxon
8/20/2007
$32,000,000
Agensys
7/12/2007
$41,300,000
Athersys
6/12/2007
$65,000,000
Singulex
6/7/2007
$19,100,000
Sientra
4/18/2007
$85,000,000
Innovative Spinal Technologies
3/31/2007
$18,999,800
ARYx Therapeutics
3/22/2007
$30,399,700
ChemoCentryx
3/22/2007
$29,840,000
Targanta Therapeutics
2/12/2007
$70,000,000
InteKrin Therapeutics
1/11/2007
$23,000,000
Cerenis Therapeutics
11/13/2006
$53,500,000
ChemoCentryx
8/24/2006
$17,700,000
Biodel
8/2/2006
$21,000,000
Acceleron Pharma
8/2/2006
$30,000,000
CoGenesys
6/12/2006
$55,000,000
MacroGenics
5/17/2006
$45,000,000
Amnis
3/31/2006
$8,250,000
Insulet
2/16/2006
$50,000,000
Cerimon Pharmaceuticals
10/26/2005
$70,000,000
Cerexa
8/23/2005
$50,000,000
Innovative Spinal Technologies
8/2/2005
$39,000,000
Orphan Medical
6/27/2005
$80,000,000
superDimension
6/2/2005
$27,000,000
Volcano
2/24/2005
$15,000,000
Predix Pharmaceuticals Holdings
1/25/2005
$43,000,000
Emphasys Medical
6/23/2004
$27,500,000
Adhezion Biomedical
5/20/2004
$10,500,000
EXIMIAS Pharmaceutical
3/31/2004
$63,500,000
XenoPort
2/4/2004
$37,000,000
Agensys
3/5/2002
$42,800,000

 

Investor Contacts

Title
Name
Email & Social
Partner
Mona Ashiya
  Mona Ashiya LinkedIn Profile  Mona Ashiya Twitter Account  Mona Ashiya News  Mona Ashiya on Facebook
Partner
David Bonita
  David Bonita LinkedIn Profile  David Bonita Twitter Account  David Bonita News  David Bonita on Facebook
Managing Partner
Sven Borho
  Sven Borho LinkedIn Profile  Sven Borho Twitter Account  Sven Borho News  Sven Borho on Facebook
Managing Partner
Carl Gordon
  Carl Gordon LinkedIn Profile  Carl Gordon Twitter Account  Carl Gordon News  Carl Gordon on Facebook
Partner
Rishi Gupta
  Rishi Gupta LinkedIn Profile  Rishi Gupta Twitter Account  Rishi Gupta News  Rishi Gupta on Facebook
General Partner
Geoffrey Hsu
  Geoffrey Hsu LinkedIn Profile  Geoffrey Hsu Twitter Account  Geoffrey Hsu News  Geoffrey Hsu on Facebook
Partner
Chau Khuong
  Chau Khuong LinkedIn Profile  Chau Khuong Twitter Account  Chau Khuong News  Chau Khuong on Facebook
General Partner
Carter Neild
  Carter Neild LinkedIn Profile  Carter Neild Twitter Account  Carter Neild News  Carter Neild on Facebook
General Partner
Jonathan Silverstein
  Jonathan Silverstein LinkedIn Profile  Jonathan Silverstein Twitter Account  Jonathan Silverstein News  Jonathan Silverstein on Facebook
General Partner
Scotland Stevens
  Scotland Stevens LinkedIn Profile  Scotland Stevens Twitter Account  Scotland Stevens News  Scotland Stevens on Facebook

 

Funds

Our database includes the following fund closing(s) for OrbiMed. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
OrbiMed Royalty & Credit Opportunities III
7/3/2019
$889,835,000
OrbiMed Asia Partners III
6/28/2017
$431,530,000
OrbiMed Israel Partners II
5/23/2016
$307,000,000
OrbiMed Private Investments VI
12/21/2015
$950,000,000
OrbiMed Royalty Opportunities II
1/30/2015
$924,000,000
OrbiMed Asia Partners II
9/9/2014
$325,000,000
OrbiMed Private Investments V
11/1/2013
$735,000,000
Orbimed Healthcare Investments Trust
10/31/2013
$182,260,000
OrbiMed Global Healthcare Fund
10/15/2013
$160,000,000
OrbiMed Partners II
7/12/2013
$1,643,696,853
OrbiMed Israel Partners
4/18/2011
$222,000,000
OrbiMed Partners
3/13/2009
$2,440,302,816

 

Portfolio Companies

OrbiMed has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
89Bio
AbCellera
Acceleron Pharma
ACELYRIN
Acerta Pharma
Acutus Medical
Adagio Therapeutics
ADARx Pharmaceuticals
Adela
Adhezion Biomedical
Adicet Bio
Adimab
Aduro BioTech
Aer Therapeutics
Aerin Medical
Aerpio Pharmaceuticals
Agensys
Alector
Alentis Therapeutics
Alpine Immune Sciences
Ambit Biosciences
Amnis
Amolyt Pharma
Apollomics
Apoptos
Aragon Pharmaceuticals
Armo Bio Sciences
ArriVent Biopharma
Arsanis
Arteaus Therapeutics
Arvinas
ARYx Therapeutics
Asceneuron
Aspen Neuroscience
Athersys
Atox Bio
Attenua
Audentes Therapeutics
Augmedix
Avedro
Avitide
binx health
BioAge Labs
Biodel
Biolex
BlossomHill Therapeutics
Bonovo Orthopedics
Brenig Therapeutics
Candid Therapeutics
Capstan Therapeutics
CardiAQ Valve Technologies
Cardioxyl Pharmaceuticals
Caris Life Sciences
Carrot Fertility
CBT Pharmaceuticals
Century Therapeutics
CeraPedics
Cerenis Therapeutics
Cerexa
Cerimon Pharmaceuticals
Charm Therapeutics
ChemoCentryx
Chinook Therapeutics
Civitas Therapeutics
Cleave Biosciences
Cleave Therapeutics
Clementia Pharmaceuticals
Clover Biopharmaceuticals
CoGenesys
Compass Therapeutics
Complete Genomics
Congruence Therapeutics
Constellation Pharmaceuticals
Convergent Therapeutics
Corteria Pharmaceuticals
Corvus Pharmaceuticals
Crinetics Pharmaceuticals
Crossover Health
Crown Bioscience
Cyrus Biotechnology
Cytek Biosciences
Decibel Therapeutics
Delfi Diagnostics
DFINE
Dimension Therapeutics
Disc Medicine
Domain Surgical
E-Scape Bio
Edgewise Therapeutics
Electra Therapeutics
Emphasys Medical
Enobia Pharma
Entos
Epigenic Therapeutics
Erasca
EXIMIAS Pharmaceutical
Exsilio Therapeutics
Fore Biotherapeutics
ForteBio
Forward Therapeutics
Frontera Therapeutics
Fusion Pharmaceuticals
Galecto
Garuda Therapeutics
Gelesis
Gemini Therapeutics
GENEWIZ
Gennao Bio
GentiBio
Glaukos
Good Start Genetics
Graphite Bio
GrayBug Vision
Guardant Health
Harbour BioMed
Harpoon Therapeutics
Health Catalyst
Iambic Therapeutics
iECURE
Igenica
Ikena Oncology
Imara Inc.
ImmPACT Bio USA
Innovative Spinal Technologies
Inspire Medical Systems
Insulet
InteKrin Therapeutics
Intellia Therapeutics
Intercept Pharmaceuticals
InventisBio
Invitae
Iroko Pharmaceuticals
Janux Therapeutics
Kala Pharmaceuticals
Kalidex Pharmaceuticals
Kinnate Biopharma
Koya Medical
Kreogene
Kyn Therapeutics
Leal Therapeutics
LogicBio Therapeutics
Loxo Oncology
MacroGenics
Magenta Medical
Marina Biotech
MBX Biosciences
MDClone
MID Labs
MinervaX
Minnow Medical
Mirador Therapeutics
MiroBio
MobileODT
Modis Therapeutics
Nabriva Therapeutics
Nanotronics
Natera
NeurAxon
Neurogastrx
NeuroPace
NextCure
Nucleix
Odyssey Therapeutics
Olema Oncology
OmniGuide Surgical
ORIC Pharmaceuticals
Ornim
Orphan Medical
Otonomy
Pacira Pharmaceuticals
Pandion Therapeutics
Passage Bio
Pathalys Pharma
Peloton Therapeutics
PIC Therapeutics
PierianDx
Pionyr Immunotherapeutics
PMV Pharmaceuticals
Practice Fusion
Predix Pharmaceuticals Holdings
Prelude Therapeutics
Prevail Therapeutics
Principia Biopharma
ProfoundBio
Promentis Pharmaceuticals
ProNAi Therapeutics
Puma Biotechnology
Q32 Bio
Rampart Bioscience
RayzeBio
RDD Pharma
ReCode Therapeutics
Relypsa
Rempex Pharmaceuticals
Repare Therapeutics
resTORbio
ReViral
RHYTHM Health
Roka Bioscience
RPS Diagnostics
Scorpion Therapeutics
scPharmaceuticals
Scribe Therapeutics
Selecta Biosciences
Seragon Pharmaceuticals
SI-BONE
Sientra
Sikka Software
Silverback Therapeutics
Singulex
Sionna Therapeutics
SmartZyme
Sonendo
Sparrow Pharmaceuticals
SpringWorks Therapeutics
Star Therapeutics
Sublimity Therapeutics
superDimension
Symbiomix Therapeutics
Syndax Pharmaceuticals
Synlogic
Synthorx
TandemAI
Targanta Therapeutics
Terns Pharmaceuticals
Terremoto Biosciences
TherAchon
Theseus Pharmaceuticals
Third Harmonic Bio
TigerText
Tisbury Pharmaceuticals
TP Therapeutics
Treato
Treeline Biosciences
Tricida
Triveni Bio
True North Therapeutics
Turnstone Biologics
Tyra Biosciences
Tyto Care
Unum Therapeutics
Upstream Bio
Vanqua Bio
VelosBio
Ventyx Biosciences
ViewRay
Vigil Neuroscience
Volcano
XenoPort

 

 

 

 

Browse more private equity investors:

Optimas Group | Origami Capital Partners

 

Share this article

 

About Our Private Equity Investor Database

The private equity investor data above is provided by VentureDeal.com, a leading provider of private equity tech investment transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.